NASDAQ:ICPT

Intercept Pharmaceuticals SEC Filings & 10K Form

$21.56
+0.06 (+0.28 %)
(As of 06/11/2021 12:00 AM ET)
Add
Compare
Today's Range
$20.91
$21.90
50-Day Range
$15.46
$24.50
52-Week Range
$13.88
$83.57
Volume556,023 shs
Average Volume1.12 million shs
Market Capitalization$714.97 million
P/E RatioN/A
Dividend YieldN/A
Beta1.54

Intercept Pharmaceuticals (NASDAQ:ICPT) SEC Filings

DateFilerForm TypeView
06/10/2021
9:06 AM
Intercept Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
06/07/2021
7:15 AM
Intercept Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2021
6:00 PM
Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2021
6:03 PM
Intercept Pharmaceuticals (Issuer)
SBLENDORIO GLENN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2021
6:03 PM
Intercept Pharmaceuticals (Issuer)
SANTINI GINO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2021
6:02 PM
Intercept Pharmaceuticals (Issuer)
Miller-Rich Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2021
6:02 PM
Gottesdiener Keith Michael (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2021
6:01 PM
Fundaro Paolo (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2021
6:01 PM
Intercept Pharmaceuticals (Issuer)
ROSA-BJORKESON DAGMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2021
6:01 PM
BRADBURY DANIEL (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2021
6:00 PM
Benatti Luca (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2021
6:00 PM
AKKARAJU SRINIVAS (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2021
4:21 PM
Intercept Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2021
6:00 PM
Intercept Pharmaceuticals (Issuer)
Richardson Linda M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2021
6:01 PM
Cawkwell Gail (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
6:00 PM
Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2021
6:16 AM
Intercept Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2021
6:00 PM
Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2021
3:31 PM
Intercept Pharmaceuticals (Filer)
Form PRE 14A
04/05/2021
6:03 PM
Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2021
6:03 PM
Intercept Pharmaceuticals (Issuer)
Venezia Rocco (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2021
6:02 PM
Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2021
6:02 PM
Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2021
6:01 PM
Intercept Pharmaceuticals (Issuer)
Venezia Rocco (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/05/2021
6:00 PM
Intercept Pharmaceuticals (Issuer)
ROSA-BJORKESON DAGMAR (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/01/2021
6:00 PM
Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
6:51 PM
AKKARAJU SRINIVAS (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2021
7:05 AM
Intercept Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2021
6:01 PM
Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:00 PM
Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
6:01 PM
Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
6:15 AM
Intercept Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2021
3:30 PM
Intercept Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/17/2021
6:04 PM
Intercept Pharmaceuticals (Issuer)
Richardson Linda M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
6:01 PM
DeFrancesco Lisa (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/17/2021
6:01 PM
Intercept Pharmaceuticals (Issuer)
Richardson Linda M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/17/2021
6:00 PM
Cawkwell Gail (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2021
12:10 PM
Intercept Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/10/2021
6:00 PM
Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2021
10:03 AM
Intercept Pharmaceuticals (Subject)
Form SC 13G/A
02/08/2021
9:25 AM
FMR LLC (Filed by)
Intercept Pharmaceuticals (Subject)
Form SC 13G/A
02/02/2021
6:00 PM
Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
6:02 PM
Freedberg Jared (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
6:01 PM
Freedberg Jared (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/26/2021
6:02 PM
Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
6:01 PM
Intercept Pharmaceuticals (Issuer)
Kapadia Sandip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
6:01 PM
Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
6:01 PM
Campagna Jason (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
6:01 PM
Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
6:00 PM
Cawkwell Gail (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
3:30 PM
Intercept Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2021
8:32 AM
FIRST TRUST PORTFOLIOS LP (Filed by)
Intercept Pharmaceuticals (Subject)
Form SC 13G
01/11/2021
6:01 PM
BALL BRYAN (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
6:00 PM
BALL BRYAN (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/05/2021
6:01 PM
Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
6:01 PM
Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
6:01 PM
Intercept Pharmaceuticals (Issuer)
Kim Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
6:01 PM
Intercept Pharmaceuticals (Issuer)
Kapadia Sandip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
6:01 PM
Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
6:00 PM
Campagna Jason (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
6:00 PM
Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
6:00 PM
Cawkwell Gail (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
6:00 PM
Intercept Pharmaceuticals (Issuer)
Kapadia Sandip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2020
7:06 AM
Intercept Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2020
6:00 PM
Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2020
6:00 PM
Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2020
6:00 PM
Intercept Pharmaceuticals (Issuer)
Sullivan Ryan T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2020
6:00 PM
Cawkwell Gail (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2020
6:00 PM
Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2020
3:03 PM
Intercept Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2020
6:15 AM
Intercept Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2020
6:15 AM
Intercept Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2020
6:02 PM
Campagna Jason (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
6:02 PM
Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
6:02 PM
Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
6:01 PM
Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
6:01 PM
Intercept Pharmaceuticals (Issuer)
Kim Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
6:00 PM
Intercept Pharmaceuticals (Issuer)
Kapadia Sandip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
6:00 PM
Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
6:00 PM
Campagna Jason (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2020
10:10 AM
Intercept Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2020
6:00 PM
Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2020
3:30 PM
Genextra S.p.A. (Filed by)
Intercept Pharmaceuticals (Subject)
Form SC 13G/A
08/25/2020
6:00 PM
Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
6:00 PM
Campagna Jason (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2020
7:13 PM
Genextra S.p.A. (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2020
7:10 PM
Intercept Pharmaceuticals (Issuer)
Micheli Francesco (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2020
7:06 PM
Fundaro Paolo (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2020
6:01 PM
Intercept Pharmaceuticals (Issuer)
Sullivan Ryan T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2020
6:00 PM
Cawkwell Gail (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2020
6:00 PM
Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2020
3:04 PM
Intercept Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2020
6:15 AM
Intercept Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2020
4:00 PM
Intercept Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2020
6:03 PM
Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
6:02 PM
Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
6:02 PM
Intercept Pharmaceuticals (Issuer)
Kim Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
6:01 PM
Intercept Pharmaceuticals (Issuer)
Kapadia Sandip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
6:01 PM
Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
6:00 PM
Campagna Jason (Reporting)
Intercept Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 6/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.